| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/29/2004 | CN1533400A Probes, system and methods for drug discovery |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533398A Novel method for synthesis of (2S,3aS,7aS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use of synthesis of perindopril |
| 09/29/2004 | CN1532207A Polyethylene glycol derivatives of thymosin alphal |
| 09/29/2004 | CN1532205A Method for producing carnosine |
| 09/29/2004 | CN1532204A Process for preparing glycyl gtutamine |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/28/2004 | US6797720 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | US6797700 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797522 Solid phase synthesis; libraries; enzyme inhibitors; chromatography |
| 09/28/2004 | US6797461 Tryptase substrates and assay for tryptase activity using same |
| 09/28/2004 | US6797272 Enhanced immunogenicity using leukotoxin chimeras |
| 09/24/2004 | WO2005111058A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/23/2004 | WO2004080983A1 Novel lactams and uses thereof |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004052304A3 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | WO2003079403A3 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003059436A3 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 09/23/2004 | WO2003043518A3 Methods and products for oral care |
| 09/23/2004 | US20040186301 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 09/23/2004 | US20040185526 Preparing N-benzyloxycarbonyl- alpha -L-aspartyl-L-phenylalanine methyl ester (Z-APM) by high-conversion enzymatic coupling of N-benzyloxycarbonyl-L-aspartic acid (Z-Asp) and L-phenylalanine methyl ester (L-PM); artificial sweetners |
| 09/23/2004 | US20040185525 Process for producing peptide |
| 09/23/2004 | US20040185520 Compounds and methods for detecting tripeptidyl protease I |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/22/2004 | EP1460084A1 Novel peptide sy |
| 09/22/2004 | EP1458747A1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458745A2 SUBSTITUTED AMINO CARBOXAMIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| 09/22/2004 | EP1458393A1 Substituted diketopiperazines as oxytocin antagonists |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1100520B1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 09/22/2004 | EP1069118B1 Process for producing 4-thiazolylmethyl derivative |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | CN1531547A Hepatitis C tripeptide inhibitors |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1530372A Inhibitor of hecterocyclic oxoaminoethylol aminosulfonic amine reverse transcripted virus protenase |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1167711C Octahydro-6,10-dioxo-6h-pyridazino/1,2-a//1,2/diazepin-1-carboxylic derivatives, prepn. method and use for preparing therapeutically active compounds |
| 09/22/2004 | CN1167710C Pyrrolidincarbonylamino cyclic disulfides |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794531 Process for production of aspartyl dipeptide ester derivative, novel production intermediate therefor, and process for production thereof |
| 09/21/2004 | US6794518 Vitronectin receptor antagonist pharmaceuticals |
| 09/21/2004 | US6794492 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794362 Asparagine containing elastin peptide analogs |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/21/2004 | CA2076226C Substituted 1-pyrimidinylacetamide compounds |
| 09/16/2004 | WO2004078908A2 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | WO2004078780A1 Pharmaceutical composition containing l-seryl-l-leucine |
| 09/16/2004 | WO2004078708A2 Novel method for synthesising derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylic acid and the use thereof for perindopril synthesis |
| 09/16/2004 | WO2004078107A2 Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | WO2003062265A3 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/16/2004 | US20040180815 Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |
| 09/16/2004 | CA2518020A1 Alpha-keto carbonyl calpain inhibitors |
| 09/15/2004 | EP1457498A1 Novel peptide having angiotensin convertase inhibitory effect |
| 09/15/2004 | EP1455809A2 Inhibitors of hepatitis c virus |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0938326B1 Synthetic phosphopeptides for treating bone diseases |
| 09/15/2004 | CN1529712A Process for preparing dipeptide, Peptide synthase to be used therein and process for producing peptide synthase |
| 09/15/2004 | CN1529694A Method for preparing |
| 09/15/2004 | CN1528783A Bursopoietin extracting method and its use in disease treating and immune |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166631C S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |
| 09/14/2004 | US6790470 Aspartame derivative crystal and process for producing the same |
| 09/14/2004 | CA2136438C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 09/10/2004 | WO2004076478A1 PEPTIDE DERIVATIVES HAVING β-SECRETASE INHIBITORY ACTIVITY |
| 09/10/2004 | WO2004076477A1 MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075830A2 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | WO2004060913A3 Heteroaryl peptidomimetics as thrombin receptor antagonists |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/10/2004 | WO2002099045A3 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone |
| 09/10/2004 | CA2516750A1 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | CA2515975A1 Peptide derivatives having .beta.-secretase inhibitory activity |
| 09/09/2004 | US20040176472 Process for production of aspartyl dipeptide ester derivative, novel production intermediate therefor, and process for production thereof |
| 09/09/2004 | US20040176459 Prodrugs of excitatory amino acids |
| 09/09/2004 | US20040176333 2-Mercaptopropionamide derivatives; |
| 09/09/2004 | US20040176305 Novel compounds useful in pain management |
| 09/09/2004 | US20040176304 arginine-threonine-arginine (RTR) peptide complexed with N-acetyl-Proline-Glycine-Proline; autoimmune diseases: chronic inflammatory bowel diease, rheumatoid arthritis; heart ischemia; Adult respiratory distress syndromes: asthma, emphysema |
| 09/09/2004 | US20040176302 Methods for inhibiting tumor cell proliferation |
| 09/09/2004 | US20040176283 Methods and compositions for the design of synthetic vaccines |
| 09/09/2004 | US20040175777 Peptide substrate libraries comprising bifunctional fluorogenic-leaving group; specifically, 7-amino-4-carbamoylmethyl-coumarin (ACC) for profiling enzymatic activity; for drug screening enzyme inhibitors; solid phase synthesis |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/08/2004 | EP1454914A1 Tumor antigen |
| 09/08/2004 | EP1454627A1 Alpha-Keto carbonyl calpain inhibitors |